ClinicalThought

Share

Program Content

Activities

  • Identifying High-Risk Disease
    In HER2-Positive Early Breast Cancer, Who Benefits From Dual HER2-Targeted Therapy? Identifying High-Risk Disease
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 17, 2018

    Expires: October 16, 2019

Faculty

cover img faculity

Mark D. Pegram, MD

Leonard M. Miller School of Medicine
University of Miami
Miami, Florida

Provided by

ProCE Banner

Supporters

Genentech TEXT Only

Partners

GRACE

ProCE Banner